OTL
AMED

Oak Thistle LLC’s Amedisys AMED Stock Holding History

Oak Thistle LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,775
Closed -$667K – 463
2025
Q2 		$667K Sell
6,775
-8,679
-56% -$821K 0.1% 332
2025
Q1 		$1.43M Buy
15,454
+8,490
+122% +$783K 0.29% 119
2024
Q4 		$632K Buy
6,964
+3,440
+98% +$316K 0.19% 204
2024
Q3 		$340K Buy
+3,524
New +$344K 0.11% 315
2023
Q2 		– Sell
-5,657
Closed -$416K – 346
2023
Q1 		$416K Buy
+5,657
New +$489K 0.25% 187

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oak Thistle LLC's AMED Position: Q3 2025 in Review

Oak Thistle LLC sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,775 shares — an estimated $667K sold.

Oak Thistle LLC first reported a position in AMED in Q1 2023 and held it in 5 quarters. The position peaked at $1.43M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Oak Thistle LLC reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Oak Thistle LLC sold 6,775 Amedisys shares in Q3 2025, an estimated $667K.
  • Oak Thistle LLC first reported a position in Amedisys in Q1 2023 and held it in 5 quarters.
  • Oak Thistle LLC's Amedisys position peaked at $1.43M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Oak Thistle LLC's 13F filing for Q3 2025, filed 7 Oct 2025.